BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3163 related articles for article (PubMed ID: 16957569)

  • 21. Signal averaged ECG in different patterns of left ventricular hypertrophy and geometry in hypertension.
    Wojszwiłło A; Łoboz-Grudzień K; Jaroch J
    Kardiol Pol; 2003 May; 58(5):335-43. PubMed ID: 14523481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
    Okin PM; Devereux RB; Gerdts E; Snapinn SM; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Lindholm LH; Dahlöf B;
    Circulation; 2006 Mar; 113(12):1588-96. PubMed ID: 16534012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE Study).
    Wachtell K; Palmieri V; Gerdts E; Bella JN; Aurigemma GP; Papademetriou V; Dahlöf B; Aalto T; Ibsen H; Rokkedal JE; Devereux RB
    Am J Cardiol; 2010 Oct; 106(7):999-1005. PubMed ID: 20854964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Independent association of coronary flow reserve with left ventricular relaxation and filling pressure in arterial hypertension.
    Galderisi M; de Simone G; D'Errico A; Sidiropulos M; Viceconti R; Chinali M; Mondillo S; de Divitiis O
    Am J Hypertens; 2008 Sep; 21(9):1040-6. PubMed ID: 18600214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular diastolic dysfunction in normotensive diabetic patients in various age strata.
    Masugata H; Senda S; Goda F; Yoshihara Y; Yoshikawa K; Fujita N; Daikuhara H; Okuyama H; Taoka T; Kohno M
    Diabetes Res Clin Pract; 2008 Jan; 79(1):91-6. PubMed ID: 17919764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arterial stiffness is associated with left ventricular diastolic function in patients with cardiovascular risk factors: early detection with the use of cardio-ankle vascular index and ultrasonic strain imaging.
    Mizuguchi Y; Oishi Y; Tanaka H; Miyoshi H; Ishimoto T; Nagase N; Oki T
    J Card Fail; 2007 Nov; 13(9):744-51. PubMed ID: 17996823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is albuminuria an indicator of myocardial dysfunction in diabetic patients without overt heart disease? A study with Doppler strain and strain rate imaging.
    Shim CY; Park S; Choi EY; Kang SM; Cha BS; Ha JW; Rim SJ; Lee HC; Chung N
    Metabolism; 2008 Apr; 57(4):448-52. PubMed ID: 18328343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between systolic and diastolic function of the left ventricle in patients with impaired relaxation of the left ventricle without symptoms of heart failure. Attempt at quantitative estimation of diastolic function in the impaired relaxation stage].
    Kosmala W; Spring A; Witkowska M
    Pol Arch Med Wewn; 1997 Nov; 98(11):414-23. PubMed ID: 9594559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age dependency in the timing of mitral annular motion in relation to ventricular filling in healthy subjects: Umea General Population Heart Study.
    Bukachi F; Waldenström A; Mörner S; Lindqvist P; Henein MY; Kazzam E
    Eur J Echocardiogr; 2008 Jul; 9(4):522-9. PubMed ID: 18490308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.
    Wachtell K; Bella JN; Rokkedal J; Palmieri V; Papademetriou V; Dahlöf B; Aalto T; Gerdts E; Devereux RB
    Circulation; 2002 Mar; 105(9):1071-6. PubMed ID: 11877357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study.
    Zanchetti A; Cuspidi C; Comarella L; Rosei EA; Ambrosioni E; Chiariello M; Leonetti G; Mancia G; Pessina AC; Salvetti A; Trimarco B; Volpe M; Grassivaro N; Vargiu G
    J Hypertens; 2007 Oct; 25(10):2158-67. PubMed ID: 17885561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
    Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.
    Palmieri V; Wachtell K; Gerdts E; Bella JN; Papademetriou V; Tuxen C; Nieminen MS; Dahlöf B; de Simone G; Devereux RB
    Am Heart J; 2001 May; 141(5):784-91. PubMed ID: 11320367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of inertia force of late systolic aortic flow is a cause of left ventricular isolated diastolic dysfunction in patients with coronary artery disease.
    Yoshida T; Ohte N; Narita H; Sakata S; Wakami K; Asada K; Miyabe H; Saeki T; Kimura G
    J Am Coll Cardiol; 2006 Sep; 48(5):983-91. PubMed ID: 16949491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise performance during losartan- or atenolol-based treatment in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy).
    Gerdts E; Björnstad H; Devereux RB; Lund-Jhansen P; Davidsen ES; Omvik P
    Blood Press; 2006; 15(4):220-6. PubMed ID: 17060116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint.
    Wachtell K; Smith G; Gerdts E; Dahlöf B; Nieminen MS; Papademetriou V; Bella JN; Ibsen H; Rokkedal J; Devereux RB
    Am J Cardiol; 2000 Feb; 85(4):466-72. PubMed ID: 10728952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood pressure, left ventricular mass and function in adult patients after successful repair of coarctation of the aorta.
    Trojnarska O; Szyszka A; Ochotny R; Siwińska A; Cieśliński A
    Kardiol Pol; 2003 Oct; 59(10):312-9. PubMed ID: 14618215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of chronic renal insufficiency on left ventricular diastolic function in hypertensives without left ventricular hypertrophy.
    Nardi E; Cottone S; Mulè G; Palermo A; Cusimano P; Cerasola G
    J Nephrol; 2007; 20(3):320-8. PubMed ID: 17557265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Left ventricular hypertrophy in hypertension: functional aspects].
    Lombardo M; Zaini G; Colloca W; Belli C
    G Ital Cardiol; 1987 Dec; 17(12):1039-44. PubMed ID: 2972580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 159.